# HCT Versus CT in Elderly AML

> **NCT00766779** · PHASE3 · TERMINATED · sponsor: **European Society for Blood and Marrow Transplantation** · enrollment: 126 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **PROCEDURE:** hematopoietic cell transplantation
- **DRUG:** Non-Transplant treatment approach for consolidation

## Key facts

- **NCT ID:** NCT00766779
- **Lead sponsor:** European Society for Blood and Marrow Transplantation
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 126 (ACTUAL)
- **Why stopped:** Recommendation of DMC
- **Last updated:** 2021-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766779, "HCT Versus CT in Elderly AML". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00766779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*